All cash flow is not created equal. Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because ...

In the wake of Thermo Fisher Scientific, Inc.’s TMO impending acquisition of Affymetrix, Inc. AFFX, the latter has finally chosen to stick to Thermo Fisher’s $1.3 billion takeover bid. With this ...

It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" In this series, we measure how swiftly a ...

Affymetrix said today it will collaborate with XRGenomics to develop next-generation diagnostic tests for age-related diseases. The alliance builds on an existing partnership between the companies, as ...

(NASDAQ: AFFX) today announced the expansion of its license agreement with Siemens Healthcare Diagnostics for the company’s branched DNA (bDNA) technology whereby Affymetrix is the exclusive licensee ...

At first glance, the luminous image rolling across a conference room wall at Affymetrix Inc. looks like mysterious transmissions from an alien race using an intricate language we don't understand. But ...

Mindy Lee-Olsen, 408-731-5523 (Media)Vice President, Marketing ServicesorDoug Farrell, 408-731-5285 (Investors)Vice President, Investor Relations (NASDAQ:AFFX) announced today the availability of ...

Don't just count the cash, time it. It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" When ...

Unique and optimized solution provides highly sensitive and reproducible RNA amplification and labeling from archived FFPE samples for biomarker discovery and validation on industry-leading ...